High Net Worth Advisory Group LLC
- SEC CIK
- 0001919142
- Latest filing
- Jul 29, 2026
AMLX holding history
Amylyx Pharmaceuticals, Inc. in every 13F filed by High Net Worth Advisory Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMLX overviewAll 13F holders of AMLXFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −3,000−100.0% | Sold out | Holders |
| Q4 2022 | 3,000 | $110.8K | <0.1% | +1,000+50.0% | Added | Holders |
| Q3 2022 | 2,000 | $56.0K | <0.1% | +500+33.3% | Added | Holders |
| Q2 2022 | 1,500 | $29.0K | <0.1% | +1,000+200.0% | Added | Holders |
| Q1 2022 | 500 | $6.00K | <0.1% | +500 | New | Holders |